These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 29524948)

  • 1. BRIC Health Systems and Big Pharma: A Challenge for Health Policy and Management.
    Rodwin VG; Fabre G; Ayoub RF
    Int J Health Policy Manag; 2018 Mar; 7(3):201-206. PubMed ID: 29524948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Idiopathic pulmonary fibrosis in BRIC countries: the cases of Brazil, Russia, India, and China.
    Richeldi L; Rubin AS; Avdeev S; Udwadia ZF; Xu ZJ
    BMC Med; 2015 Sep; 13():237. PubMed ID: 26399999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Private initiatives and policy options: recent health system experience in India.
    Purohit BC
    Health Policy Plan; 2001 Mar; 16(1):87-97. PubMed ID: 11238435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Waste electrical and electronic equipment management and Basel Convention compliance in Brazil, Russia, India, China and South Africa (BRICS) nations.
    Ghosh SK; Debnath B; Baidya R; De D; Li J; Ghosh SK; Zheng L; Awasthi AK; Liubarskaia MA; Ogola JS; Tavares AN
    Waste Manag Res; 2016 Aug; 34(8):693-707. PubMed ID: 27422616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Health Impact Fund: making the case for engagement with pharmaceutical laboratories in Brazil, Russia, India, and China.
    Lee VC; Yao J; Zhang W
    Global Health; 2021 Sep; 17(1):101. PubMed ID: 34488801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intended and unintended impacts of price changes for drugs and medical services: Evidence from China.
    Fu H; Li L; Yip W
    Soc Sci Med; 2018 Aug; 211():114-122. PubMed ID: 29935401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Political repression, civil society and the politics of responding to AIDS in the BRICS nations.
    Gómez EJ; Harris J
    Health Policy Plan; 2016 Feb; 31(1):56-66. PubMed ID: 25858965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of health expenditures on public health in BRICS nations.
    Jakovljevic M; Timofeyev Y; Ekkert NV; Fedorova JV; Skvirskaya G; Bolevich S; Reshetnikov VA
    J Sport Health Sci; 2019 Nov; 8(6):516-519. PubMed ID: 31720060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Pharma Summit 2010: competing in the future healthcare system.
    Kibble A
    IDrugs; 2010 Apr; 13(4):228-31. PubMed ID: 20373249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoting public health research in BRICS through a multinational public health prize fund.
    Campbell M
    Indian J Med Ethics; 2014; 11(1):38-41. PubMed ID: 24509109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can a medical need clause help manage the growing costs of prescription drugs in the EU?
    Brooks E; Geyer R
    Health Econ Policy Law; 2016 Apr; 11(2):179-92. PubMed ID: 26333920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health financing in Brazil, Russia and India: what role does the international community play?
    Sridhar D; Gómez EJ
    Health Policy Plan; 2011 Jan; 26(1):12-24. PubMed ID: 20400535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lumping and splitting: the health policy agenda in India.
    Peters DH; Rao KS; Fryatt R
    Health Policy Plan; 2003 Sep; 18(3):249-60. PubMed ID: 12917266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drug for hepatitis C contributes to 13% rise in spending on prescription drugs in US.
    McCarthy M
    BMJ; 2015 Apr; 350():h2055. PubMed ID: 25888306
    [No Abstract]   [Full Text] [Related]  

  • 16. Global health in foreign policy--and foreign policy in health? Evidence from the BRICS.
    Watt NF; Gomez EJ; McKee M
    Health Policy Plan; 2014 Sep; 29(6):763-73. PubMed ID: 24072881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contemporary generic market in Japan - key conditions to successful evolution.
    Jakovljevic MB; Nakazono S; Ogura S
    Expert Rev Pharmacoecon Outcomes Res; 2014 Apr; 14(2):181-94. PubMed ID: 24450984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare financing: approaches and trends in India.
    Bajpai V; Saraya A
    Natl Med J India; 2010; 23(4):231-5. PubMed ID: 21192520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dominant logic of Big Tech in healthcare and pharma.
    Schuhmacher A; Haefner N; Honsberg K; Goldhahn J; Gassmann O
    Drug Discov Today; 2023 Feb; 28(2):103457. PubMed ID: 36427777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multinational corporations and health care in the United States and Latin America: strategies, actions, and effects.
    Jasso-Aguilar R; Waitzkin H; Landwehr A
    J Health Soc Behav; 2004; 45 Suppl(Suppl):136-57. PubMed ID: 15779471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.